UBS AM’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.9M Buy
1,358,814
+76,021
+6% +$1.59M 0.01% 802
2026
Q1
$26.5M Buy
1,282,793
+1,282,607
+689,574% +$28.3M 0.01% 788
2025
Q4
$4.03K Sell
186
-191
-51% -$4.32K ﹤0.01% 3020
2025
Q3
$9.53K Sell
377
-784,417
-100% -$18.8M ﹤0.01% 2257
2025
Q2
$16.6M Buy
784,794
+203,089
+35% +$4.64M ﹤0.01% 1122
2025
Q1
$15.5M Buy
581,705
+137,379
+31% +$3.48M ﹤0.01% 1065
2024
Q4
$11.1M Sell
444,326
-59,800
-12% -$1.66M ﹤0.01% 1202
2024
Q3
$14.7M Buy
504,126
+274,645
+120% +$7.49M ﹤0.01% 1070
2024
Q2
$6.06M Sell
229,481
-40,347
-15% -$1.11M ﹤0.01% 1390
2024
Q1
$8.14M Sell
269,828
-4,350
-2% -$130K ﹤0.01% 1072
2023
Q4
$8.31M Buy
274,178
+5,496
+2% +$147K ﹤0.01% 1062
2023
Q3
$6.94M Buy
268,682
+3,138
+1% +$87.6K ﹤0.01% 1094
2023
Q2
$8.01M Hold
265,544
﹤0.01% 1052
2023
Q1
$8.01M Buy
265,544
+13,957
+6% +$431K ﹤0.01% 1052
2022
Q4
$7.52M Sell
251,587
-4,825
-2% -$148K ﹤0.01% 1037
2022
Q3
$6.97M Sell
256,412
-60,567
-19% -$1.96M ﹤0.01% 1087
2022
Q2
$10.7M Buy
316,979
+13,660
+5% +$501K 0.01% 934
2022
Q1
$11.3M Buy
303,319
+21,591
+8% +$767K ﹤0.01% 1022
2021
Q4
$10.3M Sell
281,728
-6,965
-2% -$242K ﹤0.01% 1117
2021
Q3
$9.35M Buy
288,693
+12,825
+5% +$430K ﹤0.01% 1119
2021
Q2
$8.99M Buy
275,868
+11,803
+4% +$388K ﹤0.01% 1158
2021
Q1
$7.73M Buy
264,065
+12,188
+5% +$359K ﹤0.01% 1173
2020
Q4
$6.71M Buy
251,877
+29,918
+13% +$763K ﹤0.01% 1180
2020
Q3
$5.32M Buy
221,959
+10,596
+5% +$264K ﹤0.01% 1127
2020
Q2
$4.75M Sell
211,363
-23,178
-10% -$504K ﹤0.01% 1137
2020
Q1
$5.01M Buy
234,541
+35,706
+18% +$900K ﹤0.01% 1050
2019
Q4
$5.91M Sell
198,835
-296
-0.1% -$8.06K ﹤0.01% 1123
2019
Q3
$5.09M Sell
199,131
-93
-0% -$2.38K ﹤0.01% 1195
2019
Q2
$5.48M Buy
199,224
+1,077
+0.5% +$30.1K ﹤0.01% 1167
2019
Q1
$5.67M Sell
198,147
-532
-0.3% -$14.2K ﹤0.01% 1106
2018
Q4
$4.99M Buy
198,679
+3,733
+2% +$103K ﹤0.01% 1095
2018
Q3
$5.98M Buy
194,946
+1,953
+1% +$62.6K ﹤0.01% 1089
2018
Q2
$6.77M Sell
192,993
-9,896
-5% -$339K 0.01% 1053
2018
Q1
$6.48M Buy
202,889
+25,404
+14% +$772K 0.01% 1052
2017
Q4
$5.09M Buy
177,485
+11,617
+7% +$323K ﹤0.01% 1109
2017
Q3
$4.35M Buy
165,868
+32,834
+25% +$854K ﹤0.01% 1134
2017
Q2
$3.47M Buy
133,034
+18,403
+16% +$474K ﹤0.01% 1158
2017
Q1
$2.95M Buy
114,631
+16,916
+17% +$433K ﹤0.01% 1184
2016
Q4
$2.36M Sell
97,715
-40,573
-29% -$982K ﹤0.01% 1231
2016
Q3
$3.33M Buy
138,288
+1,008
+0.7% +$24.6K ﹤0.01% 1170
2016
Q2
$3.27M Buy
137,280
+10,094
+8% +$232K ﹤0.01% 1166
2016
Q1
$2.85M Sell
127,186
-35,932
-22% -$700K ﹤0.01% 1222
2015
Q4
$3.29M Buy
163,118
+4,103
+3% +$86.3K ﹤0.01% 1219
2015
Q3
$3.18M Buy
159,015
+33,137
+26% +$717K ﹤0.01% 1218
2015
Q2
$2.92M Sell
125,878
-229,920
-65% -$5.4M ﹤0.01% 1239
2015
Q1
$8.7M Sell
355,798
-2,330
-0.7% -$59.3K 0.01% 917
2014
Q4
$9.08M Sell
358,128
-8,589
-2% -$230K 0.01% 896
2014
Q3
$10.4M Sell
366,717
-176,168
-32% -$5.41M 0.01% 828
2014
Q2
$17.5M Sell
542,885
-171,730
-24% -$5.39M 0.02% 713
2014
Q1
$22.2M Buy
714,615
+15,013
+2% +$452K 0.02% 638
2013
Q4
$20M Buy
699,602
+38,018
+6% +$1.23M 0.02% 641
2013
Q3
$24.9M Buy
661,584
+21,011
+3% +$805K 0.03% 531
2013
Q2
$24M Buy
+640,573
New +$24.8M 0.03% 517

Other funds holding RYN

UBS AM's RYN Position: Q2 2026 in Review

UBS AM increased its Rayonier (RYN) stake by 5.9% in Q2 2026, buying an estimated $1.59M and bringing the position to 1,358,814 shares worth $28.9M. The position accounts for 0.01% of the portfolio, ranked #802.

UBS AM first reported a position in RYN in Q2 2013 and has held it in 53 quarters since. 455 funds tracked by Wall St. Rank hold RYN as of Q2 2026.

  • UBS AM held 1,358,814 shares of Rayonier worth $28.9M as of Q2 2026.
  • UBS AM bought 76,021 Rayonier shares in Q2 2026, an estimated $1.59M.
  • Rayonier made up 0.01% of UBS AM's portfolio in Q2 2026, its #802 holding.
  • UBS AM first reported a position in Rayonier in Q2 2013 and has held it in 53 quarters since.
  • 455 funds tracked by Wall St. Rank held Rayonier as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.